Series A financing round lays foundation for international growth of
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company
Stay updated with breaking news from Mika Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company
/PRNewswire/ -- Berlin-based digital health company Fosanis, the developer of Mika, Germany's first prescription DTx for all oncological indications, closed a...
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx)...
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx)...
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering